Viral Vector Pre-Clinical and Clinical cGMP Manufacturing

We offer a broad range of viral vector manufacturing platforms to support pre-clinical and human studies for viral vectors for gene and gene-modified cell therapies and vaccines.

 Pre-clinicalcGMP
Suspension

50L

200L

50L

200L

4 x 200L

1000L

Adherent

Up to 48 flatstock vessels

iCELLis® NANO

iCELLis® 500

Up to 48 flatstock vessels

iCELLis® 500

Question? We’re Here to Help.

Please contact us to learn more about our viral vector development and clinical services.

Download the “Leading Viral Vector CDMO Services for Cell and Gene Therapies” brochure to learn more about our end-to-end capabilities.